TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 0 | 67 | 67 | -107 | -80 | -122 | -35 |
| P | %wins | 100 | 100 | 100 | 0 | 0 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/17/08 18:51 | 7/16/08 | CDXC | Chromadex Corp. | DE | Health | MdCm | Medicinal Chemicals & Botanic | Chassman Margie | NY | T | P | 3 | 2.63 | 0 | 1 | 0 | 4,409 | D | -42 | -40 | -55 | 0 | 67 | 67 | -107 | -80 | -122 | ||||||
3/19/07 10:45 | 3/15/07 | SCLL | Stem Cell Innovations, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chassman Margie | NY | T | S.ed | -400 | 0.0400 | 0 | -10,000 | -5 | 187,391 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |